Literature DB >> 19133283

Exploring the in vitro formation of trimethylarsine sulfide from dimethylthioarsinic acid in anaerobic microflora of mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS.

Kevin M Kubachka1, Michael C Kohan, Karen Herbin-Davis, John T Creed, David J Thomas.   

Abstract

Although metabolism of arsenicals to form methylated oxoarsenical species has been extensively studied, less is known about the formation of thiolated arsenical species that have recently been detected as urinary metabolites. Indeed, their presence suggests that the metabolism of ingested arsenic is more complex than previously thought. Recent reports have shown that thiolated arsenicals can be produced by the anaerobic microflora of the mouse cecum, suggesting that metabolism prior to systemic absorption may be a significant determinant of the pattern and extent of exposure to various arsenic-containing species. Here, we examined the metabolism of 34S labeled dimethylthioarsinic acid (34S-DMTA(V)) by the anaerobic microflora of the mouse cecum using HPLC-ICP-MS and HPLC-ESI-MS/MS to monitor for the presence of various oxo- and thioarsenicals. The use of isotopically enriched 34S-DMTA(V) made it possible to differentiate among potential metabolic pathways for production of the trimethylarsine sulfide (TMAS(V)). Upon in vitro incubation in an assay containing anaerobic microflora of mouse cecum, 34S-DMTA(V) underwent several transformations. Labile 34S was exchanged with more abundant 32S to produce 32S-DMTA(V), a thiol group was added to yield DMDTA(V), and a methyl group was added to yield 34S-TMAS(V). Because incubation of 34S-DMTA(V) resulted in the formation of 34S-TMAS(V), the pathway for its formation must preserve the arsenic-sulfur bond. The alternative metabolic pathway postulated for formation of TMAS(V) from dimethylarsinic acid (DMA(V)) would proceed via a dimethylarsinous acid (DMA(III)) intermediate and would necessitate the loss of 34S label. Structural confirmation of the metabolic product was achieved using HPLC-ESI-MS/MS. The data presented support the direct methylation of DMTA(V) to TMAS(V). Additionally, the detection of isotopically pure 34S-TMAS(V) raises questions about the sulfur exchange properties of TMAS(V) in the cecum material. Therefore, 34S-TMAS(V) was incubated and the exchange was monitored with respect to time. The data suggest that the As-S bond associated with TMAS(V) is less labile than the As-S bond associated with DMTA(V).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133283     DOI: 10.1016/j.taap.2008.12.008

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  15 in total

1.  Arsenic exposure and toxicology: a historical perspective.

Authors:  Michael F Hughes; Barbara D Beck; Yu Chen; Ari S Lewis; David J Thomas
Journal:  Toxicol Sci       Date:  2011-07-12       Impact factor: 4.849

2.  Relationship between drinking water and toenail arsenic concentrations among a cohort of Nova Scotians.

Authors:  Zhijie M Yu; Trevor J B Dummer; Aimee Adams; John D Murimboh; Louise Parker
Journal:  J Expo Sci Environ Epidemiol       Date:  2013-12-25       Impact factor: 5.563

3.  Disruption of the arsenic (+3 oxidation state) methyltransferase gene in the mouse alters the phenotype for methylation of arsenic and affects distribution and retention of orally administered arsenate.

Authors:  Zuzana Drobna; Hua Naranmandura; Kevin M Kubachka; Brenda C Edwards; Karen Herbin-Davis; Miroslav Styblo; X Chris Le; John T Creed; Noboyu Maeda; Michael F Hughes; David J Thomas
Journal:  Chem Res Toxicol       Date:  2009-10       Impact factor: 3.739

4.  Arsenic induces structural and compositional colonic microbiome change and promotes host nitrogen and amino acid metabolism.

Authors:  Rishu Dheer; Jena Patterson; Mark Dudash; Elyse N Stachler; Kyle J Bibby; Donna B Stolz; Sruti Shiva; Zeneng Wang; Stanley L Hazen; Aaron Barchowsky; John F Stolz
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-31       Impact factor: 4.219

5.  Gut microbiome perturbations induced by bacterial infection affect arsenic biotransformation.

Authors:  Kun Lu; Peter Hans Cable; Ryan Phillip Abo; Hongyu Ru; Michelle E Graffam; Katherine Ann Schlieper; Nicola M A Parry; Stuart Levine; Wanda M Bodnar; John S Wishnok; Miroslav Styblo; James A Swenberg; James G Fox; Steven R Tannenbaum
Journal:  Chem Res Toxicol       Date:  2013-11-18       Impact factor: 3.739

6.  Arsenic metabolism by human gut microbiota upon in vitro digestion of contaminated soils.

Authors:  Tom Van de Wiele; Christina M Gallawa; Kevin M Kubachka; John T Creed; Nicholas Basta; Elizabeth A Dayton; Shane Whitacre; Gijs Du Laing; Karen Bradham
Journal:  Environ Health Perspect       Date:  2010-03-26       Impact factor: 9.031

7.  A potential synergy between incomplete arsenic methylation capacity and demographic characteristics on the risk of hypertension: findings from a cross-sectional study in an arsenic-endemic area of inner Mongolia, China.

Authors:  Yongfang Li; Da Wang; Xin Li; Quanmei Zheng; Guifan Sun
Journal:  Int J Environ Res Public Health       Date:  2015-03-31       Impact factor: 3.390

8.  In vitro intestinal bioavailability of arsenosugar metabolites and presystemic metabolism of thio-dimethylarsinic acid in Caco-2 cells.

Authors:  Larissa Leffers; Christoph A Wehe; Sabine Hüwel; Marc Bartel; Franziska Ebert; Mojtaba S Taleshi; Hans-Joachim Galla; Uwe Karst; Kevin A Francesconi; Tanja Schwerdtle
Journal:  Metallomics       Date:  2013-08       Impact factor: 4.526

9.  In vitro toxicological characterization of two arsenosugars and their metabolites.

Authors:  Larissa Leffers; Franziska Ebert; Mojtaba S Taleshi; Kevin A Francesconi; Tanja Schwerdtle
Journal:  Mol Nutr Food Res       Date:  2013-04-08       Impact factor: 5.914

10.  Gut microbiome phenotypes driven by host genetics affect arsenic metabolism.

Authors:  Kun Lu; Ridwan Mahbub; Peter Hans Cable; Hongyu Ru; Nicola M A Parry; Wanda M Bodnar; John S Wishnok; Miroslav Styblo; James A Swenberg; James G Fox; Steven R Tannenbaum
Journal:  Chem Res Toxicol       Date:  2014-02-03       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.